InVivoMAb anti-mouse NK1.1

Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells. Burrack KS et al., 2018 Apr 17, Immunity

NKp46 Receptor-Mediated Interferon-gamma Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis. Glasner A et al., 2018 Jan 16, Immunity

Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses. Moynihan KD et al., 2016 Dec, Nat Med

Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy. Ghasemi R et al., 2016 Sep 21, Nat Commun

NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Ludigs K et al., 2016 Feb 10, Nat Commun

Inflammasomes Coordinate Pyroptosis and Natural Killer Cell Cytotoxicity to Clear Infection by a Ubiquitous Environmental Bacterium. Maltez VI et al., 2015 Nov 17, Immunity

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. Mitchell DA et al., 2015 Mar 19, Nature

NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Wensveen FM et al., 2015 Apr, Nat Immunol

Suppression of Fcgamma-receptor-mediated antibody effector function during persistent viral infection. Yamada DH et al., 2015 Feb 17, Immunity

Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy. Walsh KB et al., 2014 Jun, J Virol